Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer

Daniel Shae1, Kyle W Becker1, Plamen Christov2

  • 1Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.

Nature Nanotechnology
|January 22, 2019
PubMed

Insights

Novel STING-activating nanoparticles (STING-NPs) improve the delivery of cyclic dinucleotides (CDNs) like cGAMP. These nanoparticles enhance anti-tumour immunity and therapeutic outcomes in preclinical models.

Area of Science:

  • Immunology
  • Nanotechnology
  • Drug Delivery

Background:

  • Cyclic dinucleotide (CDN) agonists targeting stimulator of interferon genes (STING) show promise as immunotherapeutics.
  • Current CDN efficacy is limited by poor cellular delivery and rapid clearance, hindering STING activation in the cytosol.

Purpose of the Study:

  • To develop rationally designed polymersomes, termed STING-activating nanoparticles (STING-NPs), for enhanced cytosolic delivery of 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP).
  • To evaluate the therapeutic potential of STING-NPs in converting immunosuppressive tumors into immunogenic, tumoricidal microenvironments.

Main Methods:

  • STING-NPs were engineered as polymersomes encapsulating the endogenous STING ligand, cGAMP.
  • The biological potency, STING signaling, and anti-tumor effects of STING-NPs were assessed in preclinical models.
  • Efficacy was evaluated in freshly isolated human melanoma tissue.

Main Results:

  • STING-NPs significantly enhanced the biological potency of cGAMP and improved STING signaling in the tumor microenvironment and sentinel lymph nodes.
  • Treatment with STING-NPs converted immunosuppressive tumors to immunogenic, tumoricidal microenvironments, inhibiting tumor growth.
  • STING-NPs improved responses to immune checkpoint blockade, induced long-term survival, and generated protective immunological memory.

Conclusions:

  • STING-NPs represent a promising nanotechnology for improving CDN delivery and enhancing cancer immunotherapy.
  • These nanoparticles demonstrate potential for improving clinical outcomes in cancer patients, including those with melanoma.

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.1K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
975
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
391
Stereoisomerism of Cyclic Compounds02:33

Stereoisomerism of Cyclic Compounds

In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
11.1K